Furthermore, the Treg-induced monocytes might be able to clear, by HO-1, the inflammation-mediated oxidative stress and contribute to reduce the infiltrating IL-17-producing cells responsible of graft rejection and GvHD progression. Here, HMOX1 is linked to graft versus host disease.